ECSP18055921A - Cocristal, método de producción del mismo, y medicamento que contiene dicho cocristal - Google Patents
Cocristal, método de producción del mismo, y medicamento que contiene dicho cocristalInfo
- Publication number
- ECSP18055921A ECSP18055921A ECSENADI201855921A ECDI201855921A ECSP18055921A EC SP18055921 A ECSP18055921 A EC SP18055921A EC SENADI201855921 A ECSENADI201855921 A EC SENADI201855921A EC DI201855921 A ECDI201855921 A EC DI201855921A EC SP18055921 A ECSP18055921 A EC SP18055921A
- Authority
- EC
- Ecuador
- Prior art keywords
- cocristal
- same
- production method
- drug containing
- cocrystal
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- HIMUHMBGRATXMK-LBPRGKRZSA-N 5-[1-[(3s)-1-prop-2-enoylpyrrolidin-3-yl]oxyisoquinolin-3-yl]-1,2-dihydro-1,2,4-triazol-3-one Chemical compound C1N(C(=O)C=C)CC[C@@H]1OC1=NC(C=2NC(=O)NN=2)=CC2=CC=CC=C12 HIMUHMBGRATXMK-LBPRGKRZSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
- C07C59/50—Mandelic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
- C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
- C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
- C07C65/10—Salicylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención proporciona un cocristal de (S)-3-(1-((1-acriloilpirrolidin-3-il)oxi)isoquinolin-3-il)-1H-1,2,4-triazol-5(4H)-ona y un ácido orgánico capaz de formar un cocristal con el compuesto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015252658 | 2015-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP18055921A true ECSP18055921A (es) | 2018-10-31 |
Family
ID=57910088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI201855921A ECSP18055921A (es) | 2015-12-24 | 2018-07-24 | Cocristal, método de producción del mismo, y medicamento que contiene dicho cocristal |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10836745B2 (es) |
| EP (1) | EP3394045B1 (es) |
| JP (1) | JP6876704B2 (es) |
| KR (1) | KR102687603B1 (es) |
| CN (1) | CN108473467B (es) |
| AR (1) | AR107132A1 (es) |
| AU (1) | AU2016375899B2 (es) |
| CA (1) | CA3009610C (es) |
| CL (1) | CL2018001725A1 (es) |
| CO (1) | CO2018006473A2 (es) |
| DK (1) | DK3394045T3 (es) |
| EA (1) | EA039213B1 (es) |
| EC (1) | ECSP18055921A (es) |
| ES (1) | ES2877089T3 (es) |
| HK (1) | HK1256362A1 (es) |
| IL (1) | IL260195A (es) |
| MX (1) | MX380656B (es) |
| PE (1) | PE20181626A1 (es) |
| PH (1) | PH12018501356A1 (es) |
| PL (1) | PL3394045T3 (es) |
| SG (1) | SG11201805331QA (es) |
| TN (1) | TN2018000221A1 (es) |
| TW (1) | TWI722080B (es) |
| UY (1) | UY37046A (es) |
| WO (1) | WO2017111179A1 (es) |
| ZA (1) | ZA201804393B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019071187A1 (en) | 2017-10-06 | 2019-04-11 | Cargill, Incorporated | STABILIZED GLYCOSIDE COMPOSITIONS OF STEVIOL AND USES THEREOF |
| CA3078200C (en) * | 2017-10-06 | 2023-09-19 | Cargill, Incorporated | Steviol glycoside solubility enhancers |
| BR112021019948A2 (pt) | 2019-04-06 | 2021-12-14 | Cargill Inc | Intensificador de solubilidade de glicosídeo de esteviol, solução aquosa de glicosídeo de esteviol, e, bebida não alcoólica |
| BR112021019811A2 (pt) | 2019-04-06 | 2021-12-07 | Cargill Inc | Composição de glicosídeo de esteviol, bebida, métodos para reduzir um atributo sensorial indesejável de uma solução aquosa de glicosídeo de esteviol, para reduzir a persistência de doçura de um componente de glicosídeo de esteviol em uma composição comestível e para reduzir o amargor de um componente de glicosídeo de esteviol em uma composição comestível, e, soluções aquosa de glicosídeo de esteviol com reduzida persistência de doçura e aquosa de glicosídeo de esteviol com reduzido amargor |
| CN110818692B (zh) * | 2019-11-08 | 2023-03-24 | 中国海洋大学 | 一种替加氟与丁香酸的共晶及其制备方法 |
| TWI845802B (zh) * | 2020-04-21 | 2024-06-21 | 健亞生物科技股份有限公司 | 硫酸羥氯喹之晶體 |
| CN116473975B (zh) * | 2023-04-11 | 2026-03-13 | 东南大学 | 奥沙普秦和异烟酰胺或吡嗪酰胺低共熔物、药物组合物及其制备方法 |
| CN117383998B (zh) * | 2023-09-28 | 2026-07-28 | 天津理工大学 | 一种共晶的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| JP2001519346A (ja) | 1997-10-07 | 2001-10-23 | シェーリング コーポレイション | 抗真菌性結晶性多形物 |
| US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6737432B2 (en) | 2001-10-31 | 2004-05-18 | Boehringer Ingelheim Pharma Kg | Crystalline form of telmisartan sodium |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US20090031844A1 (en) | 2007-02-28 | 2009-02-05 | Nsk Ltd. | Tilt-type steering apparatus |
| US7741330B1 (en) | 2009-10-12 | 2010-06-22 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase |
| US8883802B2 (en) | 2009-12-03 | 2014-11-11 | Astrazeneca Ab | Co-crystals of a triazolo [4,5-D] pyrimide platelet aggregation inhibitor |
| KR20140048968A (ko) | 2011-07-13 | 2014-04-24 | 파마시클릭스, 인코포레이티드 | 브루톤형 티로신 키나제의 억제제 |
| JO3377B1 (ar) | 2013-03-11 | 2019-03-13 | Takeda Pharmaceuticals Co | مشتقات بيريدينيل وبيريدينيل مندمج |
-
2016
- 2016-12-22 WO PCT/JP2016/089224 patent/WO2017111179A1/en not_active Ceased
- 2016-12-22 CA CA3009610A patent/CA3009610C/en active Active
- 2016-12-22 US US15/388,063 patent/US10836745B2/en active Active
- 2016-12-22 EP EP16831645.3A patent/EP3394045B1/en active Active
- 2016-12-22 CN CN201680075516.XA patent/CN108473467B/zh active Active
- 2016-12-22 ES ES16831645T patent/ES2877089T3/es active Active
- 2016-12-22 JP JP2018532473A patent/JP6876704B2/ja active Active
- 2016-12-22 AU AU2016375899A patent/AU2016375899B2/en not_active Ceased
- 2016-12-22 MX MX2018007721A patent/MX380656B/es unknown
- 2016-12-22 PL PL16831645T patent/PL3394045T3/pl unknown
- 2016-12-22 AR ARP160103985A patent/AR107132A1/es active IP Right Grant
- 2016-12-22 EA EA201891467A patent/EA039213B1/ru unknown
- 2016-12-22 TW TW105142683A patent/TWI722080B/zh active
- 2016-12-22 TN TNP/2018/000221A patent/TN2018000221A1/en unknown
- 2016-12-22 PE PE2018001163A patent/PE20181626A1/es unknown
- 2016-12-22 SG SG11201805331QA patent/SG11201805331QA/en unknown
- 2016-12-22 HK HK18115451.0A patent/HK1256362A1/zh unknown
- 2016-12-22 KR KR1020187021264A patent/KR102687603B1/ko active Active
- 2016-12-22 DK DK16831645.3T patent/DK3394045T3/da active
- 2016-12-22 UY UY0001037046A patent/UY37046A/es not_active Application Discontinuation
-
2018
- 2018-06-21 IL IL260195A patent/IL260195A/en unknown
- 2018-06-22 CL CL2018001725A patent/CL2018001725A1/es unknown
- 2018-06-22 CO CONC2018/0006473A patent/CO2018006473A2/es unknown
- 2018-06-22 PH PH12018501356A patent/PH12018501356A1/en unknown
- 2018-06-29 ZA ZA2018/04393A patent/ZA201804393B/en unknown
- 2018-07-24 EC ECSENADI201855921A patent/ECSP18055921A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018006473A2 (es) | Cocristal, método de producción del mismo, y medicamento que contiene dicho cocristal | |
| CL2018003708A1 (es) | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de ácido lisofosfatídico (lpa). | |
| CO2022002637A2 (es) | Proceso de fabricación de moduladores de cftr | |
| GT201500348A (es) | Compuestos de pirimidinodiona contra estados cardíacos | |
| CU20170015A7 (es) | Compuesto de (pirazolilamino) pirimidinil biciclo (3.2.1)oct-8-il | |
| CO2017001608A2 (es) | Compuestos fusionados de 11 miembros y fungicidas agrícolas/hortícolas que los contienen | |
| MX2016010956A (es) | Capas implantables que comprenden una region presionada. | |
| AR101995A1 (es) | COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6 | |
| UA118149C2 (uk) | Інгібітор jak | |
| UY36175A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| CL2017001511A1 (es) | Derivados de piperidina como inhibidores de hdac1/2. | |
| MX2017009540A (es) | Compuestos de piperidina urea 4-metilsulfonil-sustituidos para el tratamiento de miocardiopatia dilatada (mcd). | |
| MX2020004666A (es) | Compuestos de pilocarpina con ácido lipoico para el tratamiento de trastornos oculares. | |
| EA201691600A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений | |
| MX2015015562A (es) | Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2. | |
| MX2021012440A (es) | Farmacos precursores de oxabicicloheptanos. | |
| CO2018007008A2 (es) | "procesos mejorados para la preparación de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo" | |
| EA201691999A1 (ru) | Новые сульфониламинобензамидные соединения | |
| CL2019002025A1 (es) | Derivados de pirrolotriazina como inhibidor de cinasas. | |
| CL2016001745A1 (es) | Ácido (s)-3'-metil-abscísico y ésteres del mismo | |
| MX387349B (es) | Compuesto que inhibe la formación de complejo de c-myc/max/adn. | |
| TH1701003495A (th) | สารประกอบไตรอะโซโลไพริมิดีนและการใช้สารประกอบนี้ | |
| AR107790A1 (es) | Formas sólidas de una tienopirimidindiona inhibidora de acc y métodos de producción de la misma | |
| GB201705502D0 (en) | Antimalarial medicine intermediates 2,4-diclorobenzoic acid synthesis | |
| TH1701002897A (th) | สารประกอบ n-((เฮท)แอริลเมธิล)-เฮเทโรแอริล-คาร์บอกแซมีดเป็นตัวยับยั้งพลาสมาแคลลิเครอิน |